Cash flow IBM

Stocks

IBM

US4592001014

IT Services & Consulting

Market Closed - NYSE 16:00:02 2026-08-26 EDT			Pre-market 07:37:23
229.87 ^USD	-1.84%		229.98	+0.05%

08-26	IBM completes the acquisition of HRL Laboratories
08-26	IBM Completes HRL Laboratories Purchase	MT

2b9bbff9508a6.DIk32ggxYbTZg1IZJLZ-Yh7PqCLUfFJ3sZtUqSUMXjY.XsJTsnt3J-6UsARtb4Q3Liqp92fkSiYG190D5lx8CHprx02RfmIZ1ZT2Aw

Published financial data: IBM

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	56.57B	59.88B	61.12B	62.04B	66.8B
Finance Div. Revenues	780M	651M	737M	709M	737M
Other Revenues, Total	-	-	-	-	-1M
Total Revenues	57.35B	60.53B	61.86B	62.75B	67.54B
Cost of Goods Sold, Total	25.33B	27.44B	27.18B	26.83B	27.84B
Finance Div. Operating Exp.	534M	406M	382M	369M	403M
Gross Profit	31.49B	32.69B	34.3B	35.55B	39.3B
Selling General & Admin Expenses, Total	19.8B	19.2B	18.48B	19.28B	19.33B
R&D Expenses	6.49B	6.57B	6.78B	7.48B	8.31B
Other Operating Expenses	-577M	-642M	-852M	-996M	-964M
Other Operating Expenses, Total	25.71B	25.12B	24.4B	25.76B	26.67B
Operating Income	5.77B	7.57B	9.9B	9.79B	12.62B
Interest Expense, Total	-1.16B	-1.22B	-1.61B	-1.71B	-1.94B
Interest And Investment Income	52M	162M	670M	747M	645M
Net Interest Expenses	-1.1B	-1.05B	-937M	-965M	-1.29B
Currency Exchange Gains (Loss)	-1M	500M	-99M	-57M	-352M
Other Non Operating Income (Expenses)	247M	104M	255M	338M	233M
EBT, Excl. Unusual Items	4.92B	7.12B	9.11B	9.1B	11.21B
Restructuring Charges	-181M	-50M	-438M	-696M	-670M
Merger & Related Restructuring Charges	-43M	-18M	-33M	-123M	-207M
Gain (Loss) On Sale Of Investments	133M	-278M	39M	20M	-7M
Gain (Loss) On Sale Of Assets	35M	279M	8M	605M	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-22M	-5.89B	-	-3.11B	-
EBT, Incl. Unusual Items	4.84B	1.16B	8.69B	5.8B	10.33B
Income Tax Expense	124M	-626M	1.18B	-218M	-242M
Earnings From Continuing Operations	4.71B	1.78B	7.51B	6.02B	10.57B
Earnings Of Discontinued Operations	1.03B	-143M	-12M	8M	22M
Net Income to Company	5.74B	1.64B	7.5B	6.02B	10.59B
Net Income - (IS)	5.74B	1.64B	7.5B	6.02B	10.59B
Net Income to Common Incl Extra Items	5.74B	1.64B	7.5B	6.02B	10.59B
Net Income to Common Excl. Extra Items	4.71B	1.78B	7.51B	6.02B	10.57B
Per Share Items
Net EPS - Basic	6.41	1.82	8.23	6.53	11.36
Basic EPS - Continuing Operations	5.26	1.97	8.25	6.53	11.34
Basic Weighted Average Shares Outstanding	896M	903M	911M	922M	932M
Net EPS - Diluted	6.35	1.79	8.14	6.43	11.16
Diluted EPS - Continuing Operations	5.21	1.95	8.15	6.42	11.14
Diluted Weighted Average Shares Outstanding	905M	912M	922M	937M	949M
Normalized Basic EPS	3.43	4.93	6.25	6.17	7.52
Normalized Diluted EPS	3.4	4.88	6.18	6.07	7.39
Dividend Per Share	6.56	6.59	6.63	6.67	6.71
Payout Ratio	102.19	362.9	80.51	102.06	59.05
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	12.19B	12.37B	13.63B	12.89B	16.17B
EBITA	8.3B	9.96B	11.52B	11.62B	14.79B
EBIT	5.77B	7.57B	9.9B	9.79B	12.62B
EBITDAR	13.63B	13.62B	14.92B	14.2B	17.48B
Total Revenues (As Reported)	57.35B	60.53B	61.86B	62.75B	67.54B
Effective Tax Rate - (Ratio)	2.56	-54.15	13.53	-3.76	-2.34
Current Domestic Taxes	535M	575M	687M	-183M	-1.59B
Current Foreign Taxes	1.34B	1.68B	1.59B	2.3B	2.3B
Total Current Taxes	1.88B	2.25B	2.28B	2.12B	716M
Deferred Domestic Taxes	-1.73B	-3.13B	-1.53B	-2.54B	-249M
Deferred Foreign Taxes	-25M	252M	428M	203M	-708M
Total Deferred Taxes	-1.75B	-2.88B	-1.1B	-2.34B	-957M
Normalized Net Income	3.07B	4.45B	5.7B	5.69B	7.01B
Interest Capitalized	3M	5M	9M	12M	4M
Interest on Long-Term Debt	-	-	-	-	-
Non-Cash Pension Expense	1.14B	6.46B	-147M	3.35B	-49M
Supplemental Operating Expense Items
Advertising Expense	1.41B	1.33B	1.24B	1.17B	1.13B
Selling and Marketing Expenses	1.41B	1.33B	1.24B	1.17B	1.13B
Research And Development Expense From Footnotes	6.49B	6.57B	6.78B	7.48B	8.31B
Net Rental Expense, Total	1.44B	1.25B	1.29B	1.31B	1.31B
Imputed Operating Lease Interest Expense	221M	223M	293M	305M	330M
Imputed Operating Lease Depreciation	1.22B	1.02B	999M	1B	978M
Stock-Based Comp., COGS (Total)	145M	164M	190M	223M	269M
Stock-Based Comp., R&D Exp. (Total)	218M	258M	328M	398M	542M
Stock-Based Comp., SG&A Exp. (Total)	555M	566M	616M	690M	904M
Stock-Based Comp., Other (Total)	64M	-	-	-	-
Total Stock-Based Compensation	982M	988M	1.13B	1.31B	1.72B

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	6.65B	7.89B	13.07B	13.95B	13.59B
Short Term Investments	600M	852M	373M	644M	830M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	7.25B	8.74B	13.44B	14.59B	14.42B
Accounts Receivable, Total	7.22B	7B	7.72B	7.24B	8.59B
Other Receivables	1B	677M	629M	918M	1.05B
Total Receivables	8.22B	7.68B	8.35B	8.16B	9.65B
Inventory	1.65B	1.55B	1.16B	1.29B	1.22B
Prepaid Expenses	2.64B	1.88B	1.77B	1.51B	1.82B
Finance Division Loans and Leases Current	7.22B	6.85B	6.1B	6.26B	7.34B
Finance Division Other Current Assets, Total	793M	939M	692M	900M	1.13B
Restricted Cash	307M	103M	21M	214M	54M
Other Current Assets, Total	1.46B	1.38B	1.38B	1.56B	1.32B
Total Current Assets	29.54B	29.12B	32.91B	34.48B	36.94B
Gross Property Plant And Equipment	23.31B	21.57B	21.34B	20.89B	21B
Accumulated Depreciation	-14.39B	-13.36B	-12.62B	-11.96B	-11.98B
Net Property Plant And Equipment	8.92B	8.21B	8.72B	8.93B	9.03B
Long-term Investments	206M	1.61B	1.59B	1.69B	1.75B
Goodwill	55.64B	55.95B	60.18B	60.71B	67.72B
Other Intangibles, Total	12.51B	11.18B	11.04B	10.66B	11.39B
Finance Division Loans and Leases Long-Term	5.42B	5.81B	5.77B	5.35B	7.71B
Deferred Tax Assets Long-Term	7.37B	6.26B	6.66B	6.98B	8.61B
Deferred Charges Long-Term	924M	866M	842M	788M	825M
Other Long-Term Assets, Total	11.47B	8.24B	7.54B	7.59B	7.91B
Total Assets	132B	127B	135B	137B	152B
Liabilities
Accounts Payable, Total	3.96B	4.05B	4.13B	4.03B	4.76B
Accrued Expenses, Total	6.9B	7.05B	6.73B	7.05B	7.98B
Short-term Borrowings	22M	8M	-	30M	-
Current Portion of Long-Term Debt	6.73B	4.68B	6.3B	4.86B	6.14B
Current Portion of Leases	1.01B	949M	941M	966M	1.08B
Current Income Taxes Payable	2.29B	2.2B	2.27B	2.03B	2.35B
Unearned Revenue Current, Total	12.65B	12.03B	13.45B	13.91B	16.1B
Other Current Liabilities	60M	546M	295M	261M	254M
Total Current Liabilities	33.62B	31.5B	34.12B	33.14B	38.66B
Long-Term Debt	44.85B	46.02B	49.74B	49.08B	53.96B
Long-Term Leases	2.52B	2.35B	2.95B	3.46B	3.42B
Unearned Revenue Non Current	3.58B	3.5B	3.53B	3.62B	4.27B
Pension & Other Post Retirement Benefits	14.44B	9.6B	10.81B	9.43B	9.02B
Deferred Tax Liability Non Current	3.96B	2.29B	1.15B	815M	781M
Other Non Current Liabilities	10.04B	9.95B	10.33B	10.23B	9.03B
Total Liabilities	113B	105B	113B	110B	119B
Common Stock, Total	57.32B	58.34B	59.64B	61.38B	63.32B
Retained Earnings	154B	150B	151B	151B	156B
Treasury Stock	-169B	-169B	-170B	-170B	-171B
Comprehensive Income and Other	-23.24B	-16.74B	-18.76B	-15.27B	-15.71B
Total Common Equity	18.9B	21.94B	22.53B	27.31B	32.65B
Minority Interest	95M	77M	80M	86M	93M
Total Equity	19B	22.02B	22.61B	27.39B	32.74B
Total Liabilities And Equity	132B	127B	135B	137B	152B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	899M	907M	917M	927M	938M
ECS Total Common Shares Outstanding	898M	906M	915M	926M	937M
Book Value / Share	21.05	24.22	24.63	29.48	34.84
Tangible Book Value	-49.25B	-45.19B	-48.68B	-44.06B	-46.46B
Tangible Book Value Per Share	-54.84	-49.87	-53.2	-47.57	-49.59
Total Debt	55.14B	54.01B	59.94B	58.4B	64.61B
Net Debt	47.89B	45.28B	46.49B	43.8B	50.19B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.45B	-711M	1.22B	-87M	-474M
Debt Equivalent Oper. Leases	11.5B	9.98B	10.34B	10.47B	10.46B
Minority Interest, Total (Incl. Fin. Div)	95M	77M	80M	86M	93M
Equity Method Investments, Total	159M	142M	125M	108M	60M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Work In Process, Total	1.44B	1.39B	1.08B	1.16B	990M
Inventories - Finished Goods, Total	208M	158M	78M	134M	230M
Land - (BS)	224M	213M	182M	179M	182M
Buildings, Total	6.05B	5.68B	5.33B	4.82B	4.81B
Machinery, Total	13.81B	12.8B	12.61B	12.69B	12.88B
Full Time Employees	282K	288K	282K	270K	264K
Accumulated Allowance for Doubtful Accounts (Supple)	218M	233M	192M	114M	99M
Order Backlog	-	-	-	-	31.9B

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	5.74B	1.64B	7.5B	6.02B	10.59B
Depreciation & Amortization - CF	3.89B	2.41B	2.11B	2.17B	2.28B
Amortization of Goodwill and Intangible Assets - (CF)	2.53B	2.4B	1.63B	1.83B	2.17B
Depreciation & Amortization, Total	6.42B	4.8B	3.74B	4B	4.45B
Amortization of Deferred Charges, Total - (CF)	-	-	660M	669M	571M
(Gain) Loss From Sale Of Asset	-307M	-122M	-170M	-652M	-39M
Stock-Based Compensation (CF)	982M	987M	1.13B	1.31B	1.72B
Other Operating Activities, Total	-2B	3.17B	-1.11B	783M	-958M
Change In Accounts Receivable	1.37B	-539M	725M	-374M	-4.28B
Change In Inventories	138M	71M	390M	-166M	70M
Change In Accounts Payable	85M	213M	65M	-13M	624M
Change in Other Net Operating Assets	367M	216M	1B	1.87B	445M
Cash from Operations	12.8B	10.44B	13.93B	13.44B	13.19B
Capital Expenditure	-2.06B	-1.35B	-1.24B	-1.05B	-1.09B
Sale of Property, Plant, and Equipment	387M	111M	321M	557M	121M
Cash Acquisitions	-3.29B	-2.35B	-5.08B	-3.29B	-8.29B
Divestitures	114M	1.27B	-4M	698M	-1M
Sale (Purchase) of Intangible assets	-706M	-626M	-565M	-637M	-647M
Investment in Marketable and Equity Securities, Total	-414M	-1.26B	-496M	-1.22B	-391M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-1M	-	1M	-	1M
Cash from Investing	-5.98B	-4.2B	-7.07B	-4.94B	-10.3B
Short Term Debt Issued, Total	-	217M	-	30M	-
Long-Term Debt Issued, Total	522M	7.8B	9.59B	5.7B	8.39B
Total Debt Issued	522M	8.02B	9.59B	5.74B	8.39B
Short Term Debt Repaid, Total	-40M	-	-7M	-	-29M
Long-Term Debt Repaid, Total	-8.6B	-6.8B	-5.08B	-6.62B	-5.49B
Total Debt Repaid	-8.64B	-6.8B	-5.09B	-6.62B	-5.52B
Issuance of Common Stock	-	-	-	745M	710M
Repurchase of Common Stock	-319M	-407M	-402M	-651M	-1.02B
Common Dividends Paid	-5.87B	-5.95B	-6.04B	-6.15B	-6.26B
Common & Preferred Stock Dividends Paid	-5.87B	-5.95B	-6.04B	-6.15B	-6.26B
Other Financing Activities, Total	949M	176M	176M	-146M	-139M
Cash from Financing	-13.35B	-4.96B	-1.77B	-7.08B	-3.83B
Foreign Exchange Rate Adjustments	-185M	-244M	9M	-359M	418M
Miscellaneous Cash Flow Adjustments	-	1M	-	1M	-
Net Change in Cash	-6.72B	1.03B	5.1B	1.07B	-520M
Supplemental Items
Cash Interest Paid	1.51B	1.4B	1.67B	1.98B	2.04B
Cash Income Tax Paid (Refund)	2.1B	1.86B	1.56B	1.72B	1.95B
Levered Free Cash Flow	4.74B	9.71B	10.82B	9.33B	13.19B
Unlevered Free Cash Flow	5.47B	10.47B	11.82B	10.4B	14.4B
Change In Net Working Capital	2.77B	-1.92B	-1.92B	15M	-1.51B
Net Debt Issued / Repaid	-8.12B	1.22B	4.5B	-880M	2.87B

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	2.51	3.65	4.71	4.49	5.46
Return on Total Capital	4.51	6.3	7.8	7.27	8.62
Return On Equity %	23.73	8.69	33.67	24.06	35.16
Return on Common Equity	23.86	8.73	33.79	24.14	35.26
Margin Analysis
Gross Profit Margin %	54.9	54	55.45	56.65	58.19
SG&A Margin	34.53	31.71	29.88	30.73	28.62
EBITDA Margin %	21.25	20.43	22.04	20.53	23.95
EBITA Margin %	14.47	16.46	18.63	18.51	21.9
EBIT Margin %	10.06	12.5	16	15.6	18.69
Income From Continuing Operations Margin %	8.22	2.94	12.15	9.59	15.65
Net Income Margin %	10.01	2.71	12.13	9.6	15.69
Net Avail. For Common Margin %	8.22	2.94	12.15	9.59	15.65
Normalized Net Income Margin	5.36	7.35	9.21	9.07	10.38
Levered Free Cash Flow Margin	8.27	16.04	17.49	14.86	19.53
Unlevered Free Cash Flow Margin	9.53	17.3	19.11	16.57	21.32
Asset Turnover
Asset Turnover	0.4	0.47	0.47	0.46	0.47
Fixed Assets Turnover	6.14	7.07	7.31	7.11	7.52
Receivables Turnover (Average Receivables)	8.42	8.42	8.3	8.3	8.44
Inventory Turnover (Average Inventory)	14.64	17.14	20.04	21.9	22.19
Short Term Liquidity
Current Ratio	0.88	0.92	0.96	1.04	0.96
Quick Ratio	0.68	0.74	0.82	0.88	0.81
Operating Cash Flow to Current Liabilities	0.38	0.33	0.41	0.41	0.34
Days Sales Outstanding (Average Receivables)	43.36	43.37	43.96	44.11	43.25
Days Outstanding Inventory (Average Inventory)	24.93	21.29	18.22	16.71	16.45
Average Days Payable Outstanding	57.92	53.44	55.75	55.42	57.76
Cash Conversion Cycle (Average Days)	10.37	11.22	6.43	5.41	1.94
Long Term Solvency
Total Debt/Equity	290.27	245.28	265.05	213.18	197.33
Total Debt / Total Capital	74.38	71.04	72.61	68.07	66.37
LT Debt/Equity	249.42	219.69	233	191.8	175.26
Long-Term Debt / Total Capital	63.91	63.63	63.83	61.24	58.95
Total Liabilities / Total Assets	85.61	82.69	83.28	80.03	78.44
EBIT / Interest Expense	5	6.22	6.16	5.72	6.52
EBITDA / Interest Expense	11.8	11.2	9.29	8.29	9.03
(EBITDA - Capex) / Interest Expense	10.01	10.09	8.51	7.68	8.47
Total Debt / EBITDA	4.05	3.97	4.02	4.11	3.7
Net Debt / EBITDA	3.51	3.33	3.12	3.09	2.87
Total Debt / (EBITDA - Capex)	4.77	4.4	4.38	4.44	3.94
Net Debt / (EBITDA - Capex)	4.14	3.69	3.4	3.33	3.06
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.94	5.54	2.2	1.44	7.62
Gross Profit, 1 Yr. Growth %	2.01	3.82	4.93	3.65	10.53
EBITDA, 1 Yr. Growth %	-0.83	1.48	16.3	1.15	25.5
EBITA, 1 Yr. Growth %	2.94	20.01	23.71	0.76	27.29
EBIT, 1 Yr. Growth %	3.15	31.1	30.77	-1.16	28.95
Earnings From Cont. Operations, 1 Yr. Growth %	19.86	-62.19	321.66	-19.95	75.74
Net Income, 1 Yr. Growth %	2.74	-71.46	357.72	-19.71	75.88
Normalized Net Income, 1 Yr. Growth %	7.71	44.8	23.58	0.3	22.99
Diluted EPS Before Extra, 1 Yr. Growth %	18.86	-62.57	317.95	-21.23	73.52
Accounts Receivable, 1 Yr. Growth %	16.25	-3.04	10.19	-6.24	18.75
Inventory, 1 Yr. Growth %	-9	-5.88	-25.19	11.02	-5.35
Net Property, Plant and Equip., 1 Yr. Growth %	-8.75	-7.9	6.2	2.38	1.11
Total Assets, 1 Yr. Growth %	-15.37	-3.6	6.29	1.43	10.72
Tangible Book Value, 1 Yr. Growth %	5	-8.25	7.73	-9.49	5.45
Common Equity, 1 Yr. Growth %	-8.23	16.1	2.68	21.19	19.56
Cash From Operations, 1 Yr. Growth %	-29.68	-18.45	33.5	-3.49	-1.87
Capital Expenditures, 1 Yr. Growth %	-21.24	-34.72	-7.5	-15.82	4.1
Levered Free Cash Flow, 1 Yr. Growth %	-69.32	104.64	11.42	-13.84	41.44
Unlevered Free Cash Flow, 1 Yr. Growth %	-66.4	91.52	12.92	-12.11	38.52
Dividend Per Share, 1 Yr. Growth %	0.77	0.61	0.61	0.6	0.6
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.32	4.74	3.86	1.82	4.49
Gross Profit, 2 Yr. CAGR %	-0.08	2.91	4.37	4.29	7.04
EBITDA, 2 Yr. CAGR %	-5.32	4.36	9.79	9.36	14.87
EBITA, 2 Yr. CAGR %	-5.97	18.2	24.6	11.96	15.69
EBIT, 2 Yr. CAGR %	-12.5	27.4	33.13	14.08	15.75
Earnings From Cont. Operations, 2 Yr. CAGR %	-18.79	-32.68	26.27	83.72	18.61
Net Income, 2 Yr. CAGR %	-21.96	-45.85	14.29	91.7	18.83
Normalized Net Income, 2 Yr. CAGR %	-12.67	66.35	39.19	13.48	13.85
Diluted EPS Before Extra, 2 Yr. CAGR %	-19.3	-33.3	25.07	81.45	16.91
Accounts Receivable, 2 Yr. CAGR %	-7.05	6.17	3.36	1.64	5.52
Inventory, 2 Yr. CAGR %	0.92	-7.45	-16.09	-8.87	2.51
Net Property, Plant and Equip., 2 Yr. CAGR %	-22.92	-8.32	-1.1	4.27	1.74
Total Assets, 2 Yr. CAGR %	-6.87	-9.68	1.22	3.83	5.97
Tangible Book Value, 2 Yr. CAGR %	-3.25	-1.85	-0.58	-1.26	-2.31
Common Equity, 2 Yr. CAGR %	-4.77	3.22	9.19	11.55	20.37
Cash From Operations, 2 Yr. CAGR %	-6.92	-24.27	4.34	13.51	-2.68
Capital Expenditures, 2 Yr. CAGR %	-5.03	-28.3	-22.3	-11.76	-6.39
Levered Free Cash Flow, 2 Yr. CAGR %	-43.39	-19.22	52.91	-1.85	11.97
Unlevered Free Cash Flow, 2 Yr. CAGR %	-40.89	-18.3	48.68	-0.22	11.77
Dividend Per Share, 2 Yr. CAGR %	1.01	0.61	0.61	0.61	0.6
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-10.35	1.6	3.88	3.05	3.72
Gross Profit, 3 Yr. CAGR %	-5.18	1.21	3.58	4.13	6.33
EBITDA, 3 Yr. CAGR %	-11.69	-3.11	6.27	4.45	14.49
EBITA, 3 Yr. CAGR %	-17.1	1.99	17.35	16.12	16.85
EBIT, 3 Yr. CAGR %	-24.13	0.12	28.51	20.58	18.84
Earnings From Cont. Operations, 3 Yr. CAGR %	-18.55	-37.06	24.09	8.47	81.02
Net Income, 3 Yr. CAGR %	-13.02	-44.2	10.3	1.6	86.27
Normalized Net Income, 3 Yr. CAGR %	-24.33	3.37	52.46	24.62	16.62
Diluted EPS Before Extra, 3 Yr. CAGR %	-18.19	-37.53	22.97	7.21	78.77
Accounts Receivable, 3 Yr. CAGR %	-2.94	-5.73	7.49	0.06	7.05
Inventory, 3 Yr. CAGR %	-0.66	-1.4	-13.79	-7.88	-7.71
Net Property, Plant and Equip., 3 Yr. CAGR %	-6.17	-18.2	-3.72	0.05	3.21
Total Assets, 3 Yr. CAGR %	2.28	-5.79	-4.64	1.29	6.08
Tangible Book Value, 3 Yr. CAGR %	29.73	-4.95	1.25	-3.65	0.93
Common Equity, 3 Yr. CAGR %	4.01	1.73	3.04	13.05	14.16
Cash From Operations, 3 Yr. CAGR %	-5.67	-10.94	-8.52	1.66	8.13
Capital Expenditures, 3 Yr. CAGR %	-15.31	-16.18	-21.95	-20.2	-6.76
Levered Free Cash Flow, 3 Yr. CAGR %	-9.88	-13.12	-10.08	26.32	10.86
Unlevered Free Cash Flow, 3 Yr. CAGR %	-7.63	-12.53	-8.99	24.8	11.31
Dividend Per Share, 3 Yr. CAGR %	1.84	0.82	0.61	0.61	0.6
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-6.42	-5.22	-4.92	1.69	4.12
Gross Profit, 5 Yr. CAGR %	-3.95	-2.42	-1.47	2.43	4.95
EBITDA, 5 Yr. CAGR %	-8.06	-5.28	-5.09	-1.07	7.32
EBITA, 5 Yr. CAGR %	-11.98	-5.48	-4.59	4.35	15.71
EBIT, 5 Yr. CAGR %	-16.44	-8.32	-5.63	5.36	22.04
Earnings From Cont. Operations, 5 Yr. CAGR %	-16.88	-20.91	-2.94	-3.39	21.87
Net Income, 5 Yr. CAGR %	-13.52	-22.21	-2.98	-8.58	13.64
Normalized Net Income, 5 Yr. CAGR %	-18.21	-8.99	-4.28	7.16	34.24
Diluted EPS Before Extra, 5 Yr. CAGR %	-15.91	-20.5	-3.05	-4.31	20.51
Accounts Receivable, 5 Yr. CAGR %	-4.68	-5.71	-0.47	-2.85	6.7
Inventory, 5 Yr. CAGR %	1.21	-0.39	-7.15	-4.46	-7.61
Net Property, Plant and Equip., 5 Yr. CAGR %	-3.81	-5.88	-4.17	-9.86	-1.57
Total Assets, 5 Yr. CAGR %	2.36	0.3	1.85	-2.06	-0.53
Tangible Book Value, 5 Yr. CAGR %	16.82	14.53	16.63	-3.49	-0.19
Common Equity, 5 Yr. CAGR %	0.71	4.52	6.05	5.55	9.65
Cash From Operations, 5 Yr. CAGR %	-5.62	-9	-1.79	-1.86	-6.23
Capital Expenditures, 5 Yr. CAGR %	-10.38	-16.05	-18.18	-14.44	-16.06
Levered Free Cash Flow, 5 Yr. CAGR %	-12.29	3.84	10.78	-8.83	-2.38
Unlevered Free Cash Flow, 5 Yr. CAGR %	-10.53	4.44	11.26	-7.85	-1.7
Dividend Per Share, 5 Yr. CAGR %	3.59	2.24	1.32	0.74	0.61